Diet and pancreatic cancer prevention

QR Code

Diet and pancreatic cancer prevention

Pancreatic cancer is without any doubt the malignancy with the poorest prognosis and the lowest survival rate. This highly aggressive disease is rarely diagnosed at an early stage and difficult to treat due to its resistance to radiotherapy and chemotherapy. Therefore, there is an urgent need to cla...

Full description

Bibliographic Details
Main Authors:	Casari, I., Falasca, Marco
Format:	Journal Article
Published:	MDPI AG 2015
Online Access:	http://hdl.handle.net/20.500.11937/60727

Similar Items

Pancreatic cancer: Current research and future directions
by: Falasca, Marco, et al.
Published: (2016)

Cancer chemoprevention by nuts: Evidence and promises
by: Falasca, Marco, et al.
Published: (2012)

Emerging role of the KRAS-PDK1 axis in pancreatic cancer
by: Ferro, R., et al.
Published: (2014)

Cancer chemoprevention with nuts.
by: Falasca, Marco, et al.
Published: (2014)

ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
by: Adamska, A., et al.
Published: (2018)

Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)

Pancreatic ductal adenocarcinoma: Current and evolving therapies
by: Adamska, A., et al.
Published: (2017)

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)

The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance
by: Elaskalani, Omar, et al.
Published: (2017)

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)

Hypermutation In Pancreatic Cancer
by: Humphris, J., et al.
Published: (2017)

Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)

Preoperative drainage in pancreatic cancer
by: Kennedy, Eugene P, et al.
Published: (2010)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Investigation of Novel Biomarkers for Pancreatic Cancer
by: Emmanouilidi, Aikaterini
Published: (2019)

Targeting thioredoxin reductase in pancreatic cancer
by: Alhadyan, Khaled
Published: (2019)

Investigation of polymer drug conjugates for pancreatic cancer
by: Anane-Adjei, Akosua Bema
Published: (2020)

Investigating therapeutic intervention strategies in pancreatic cancer
by: Malhotra, Pratibha
Published: (2023)

Association between family cancer history and risk of pancreatic cancer.
by: Schulte, A., et al.
Published: (2016)

Anti-cancer activity of the bioactive compound inositol pentakisphosphate
by: Falasca, Marco
Published: (2009)

Whole genomes redefine the mutational landscape of pancreatic cancer
by: Waddell, N., et al.
Published: (2015)

Genomic analyses identify molecular subtypes of pancreatic cancer
by: Bailey, P., et al.
Published: (2016)

Effects of cocoa polyphenol rich diet in prevention of colitis-associated colon cancer
by: Saadatdoust, Zeinab
Published: (2015)

Estimating the future burden of cancers preventable by better diet and physical activity in Australia
by: Baade, Peter, et al.
Published: (2012)

Development of Thermo-responsive materials for pancreatic cancer management
by: ElSherbeny, Amr Moustafa Said Moustafa
Published: (2024)

Mechanisms of oral bacterial virulence factors in pancreatic cancer
by: Sun, Zhong, et al.
Published: (2019)

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Surgical Management in Patients With Pancreatic Cancer: a Queensland Perspective
by: Wylie, N., et al.
Published: (2013)

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
by: Abrams, S., et al.
Published: (2018)

GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
by: Ferro, R., et al.
Published: (2018)

Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation
by: Simpson, Peter, et al.
Published: (2017)

Targeting PDK1 in cancer
by: Raimondi, C., et al.
Published: (2011)

Changes of pancreatic protein profile upon high fat diet intake in diabetic rat model
by: Teh, Ying-Hui, et al.
Published: (2024)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2015)

Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer
by: Fritschi, Lin, et al.
Published: (2015)

The role of G protein-coupled receptor 35 in pancreatic cancer
by: Kim, Minkyoung
Published: (2020)

Premalignant pancreatic cancer diagnosis using proteomic pattern analysis
by: Htike@Muhammad Yusof, Zaw Zaw
Published: (2014)

Returning individual research results for genome sequences of pancreatic cancer
by: Johns, A., et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tsveraqs9bffsm99skugm5slkb